{
    "cancelStatus": "1",
    "licStatus": "2",
    "cancelDate": "2024-03-21",
    "cancelReason": [
        "841"
    ],
    "licid": "60001193",
    "licUnit": "1",
    "validDate": "2027-03-18 00:00:00.000",
    "issueDate": "2022-03-18 00:00:00.000",
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA06000119308",
    "prodNameC": "安備咨注射劑25毫克\/毫升",
    "prodNameE": "Onbevzi 25 mg\/ml concentrate for solution for infusion",
    "indicationsName": [
        "１、轉移性大腸直腸癌(mCRC)：\r\n(１)與含有5-fluorouracil為基礎的化學療法合併使用，可以作為轉移性大腸或直腸癌病人的第一線治療。\r\n(２)與含有5-fluorouracil\/leucovorin\/oxaliplatin的化學療法合併使用，可以作為先前接受過以 fluoropyrimidine為基礎的化學療法無效且未曾接受過bevacizumab治療的轉移性大腸或直腸癌病人的治療。\r\n(３)與含有fluoropyrimidine-irinotecan-或fluoropyrimidine-oxaliplatin-為基礎的化學療法合併使用，可以做為第一線已接受過以Onbevzi併用化療後惡化之轉移性大腸或直腸癌病人的第二線治療。\r\n２、轉移性乳癌(mBC)：與paclitaxel合併使用，可以做為HER2 (-)轉移性乳癌病人的第一線治療。\r\n３、惡性神經膠質瘤(WHO第4級)-神經膠母細胞瘤：單獨使用可用於治療曾接受標準放射線治療且含Temozolomide 在內之化學藥物治療失敗之多型性神經膠母細胞瘤(Glioblastoma multiforme)復發之成人病人。\r\n４、晚期、轉移性或復發性非鱗狀非小細胞肺癌(NSCLC)：\r\n(１)與carboplatin及paclitaxel合併使用，可以作為無法切除的晚期、轉移性或復發性非鱗狀非小細胞肺癌病人的第一線治療。\r\n(２)併用erlotinib，可作為無法手術切除的晚期、轉移性或復發性且帶有表皮生長因子受體(EGFR)活化性突變的非鱗狀非小細胞肺癌病人的第一線治療。\r\n５、卵巢上皮細胞、輸卵管或原發性腹膜癌(Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer)：\r\n(１)與carboplatin及paclitaxel合併使用，接著單獨使用Onbevzi治療，可以做為對含鉑藥物具感受性之復發性卵巢上皮細胞、輸卵管或原發性腹膜癌病人的治療。\r\n(２)併用paclitaxel、topotecan或pegylated liposomal doxorubicin可以做為接受過含鉑類藥物 (platinum-based)化療治療後6個月內再復發(即，對含鉑藥物具抗藥性)、之前接受不超過2種化療療程且未曾接受過bevacizumab或其他血管內皮細胞生長因子(VEGF)抑制劑或血管內皮細胞生長因子接受器之標靶藥物(VEGF receptor-targeted agents)之復發性卵巢上皮細胞、輸卵管或原發性腹膜癌病人的治療。\r\n６、持續性、復發性或轉移性之子宮頸癌(Persistent, Recurrent, or Metastatic Cervical Cancer)：\r\n(１)與paclitaxel及cisplatin合併使用可用於治療持續性、復發性或轉移性之子宮頸癌。\r\n(２)與paclitaxel及topotecan合併使用可用於無法接受含鉑類藥物治療(platinum therapy)病人之持續性、復發性或轉移性子宮頸癌。"
    ],
    "does": "227D",
    "packageUnit": [
        {
            "packageSpec": "100支以下",
            "packageUnit": "03"
        },
        {
            "packageSpec": "4毫升或16毫升",
            "packageUnit": "L2"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": "D",
    "mainCategory": "D",
    "drBaseId": "D9F72050-BE99-498D-83CA-30CA48B9244E",
    "subCategory": [],
    "ingredientsDesc": [
        "BEVACIZUMAB"
    ],
    "restraintItemsCode": [
        "02",
        "07",
        "1D",
        "91"
    ],
    "applicantName": "台灣三星國際醫藥有限公司",
    "applicantAddr": "臺北市信義區忠孝東路4段560號13樓 (1305室)",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2027-03-18",
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "CANGENE BIOPHARMA, LLC",
            "factoryAddr": "1111 SOUTH PACA STREET, BALTIMORE, MD 21230, USA",
            "factoryCompanyAddr": "",
            "countryCode": "US",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FUS0355100",
            "factoryInfo": null,
            "qsd": null,
            "factoryMadeIn": null
        },
        {
            "factoryCode": "2",
            "factoryName": "FARMACEUTICI FORMENTI S.P.A",
            "factoryAddr": "VIA DI VITTORIO, 2, 21040 ORIGGIO (VA) ITALY",
            "factoryCompanyAddr": "VIA VITTOR PISANI 16,20124 MILANO, ITALY",
            "countryCode": "IT",
            "processCode": [
                {
                    "value": "1A",
                    "name": "二級包裝廠"
                }
            ],
            "processCodeStr": "1A;二級包裝廠",
            "factoryKind": "M",
            "factoryNo": "FDE0296000",
            "factoryInfo": null,
            "qsd": null,
            "factoryMadeIn": null
        },
        {
            "factoryCode": "2",
            "factoryName": "FUJIFILM DIOSYNTH BIOTECHNOLOGIES DENMARK APS",
            "factoryAddr": "BIOTEK ALLE 1, HILLEROD, 3400, DENMARK",
            "factoryCompanyAddr": "",
            "countryCode": "DK",
            "processCode": [
                {
                    "value": "1K",
                    "name": "原料藥製造廠"
                }
            ],
            "processCodeStr": "1K;原料藥製造廠",
            "factoryKind": "M",
            "factoryNo": "FDK0070000",
            "factoryInfo": null,
            "qsd": null,
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013000800",
            "ingredientsName": "BEVACIZUMAB",
            "ingredientsDesc": "BEVACIZUMAB",
            "concentDesc": "",
            "concent": "25.0000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01FG01"
        }
    ],
    "licBaseId": "B8D5D868-601E-4BCF-8CC5-9DBC0DB80B44"
}